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Lymphoma is a malignant tumour arising from lymphoid
tissue, with the majority of cases being in the lymph
nodes, however, in 1/4th of cases, these tumours are
found in extralymphoid tissue. Lymphoid tissue is also
found in organs having mucosa, such as the digestive
tract, salivary gland and in tracheal tissue. This collection
of lymphoid tissue is known as mucosa-associated
lymphoid tissue (MALT), and non-Hodgkin lymphoma
involving this extralymphoidal lymph tissue is known as
MALT lymphoma. It was ﬁrst reported by Isaacson and
Wright in 1983, however, it was not included as a
working diagnosis in clinical use until it was reclassiﬁed
as ‘marginal zone B-cell lymphoma’ in a 1994 Revised
European American Lymphoma (REAL) classiﬁcation. It is
rarely seen in the head and neck region, and we report
the sixth case of MALT lymphoma of the base of the
tongue. A 61-year-old man presented with dysphagia
and the feeling of a lump in his throat for 5 months.
BACKGROUND
When operating on a hypertrophic lingual tonsil
one should keep in mind the differential diagnosis.
We believe MALT lymphoma is a very rare entity
that merits reporting.1 2
CASE PRESENTATION
A 61-year-old man presented with difﬁculty in
swallowing and the feeling of a lump in throat. He
had been experiencing these progressively worsen-
ing symptoms for 5 months; he had no change in
voice and no difﬁculty breathing. He had a 30-year
history of smoking. Oral examination revealed
enlarged lingual tonsils bilaterally. Other ear, nose
and throat (ENT) examination was unremarkable.
INVESTIGATIONS
Fibreoptic laryngoscopy performed in the out-
patient clinic showed two well-deﬁned masses on
the base of the tongue, pushing the epiglottis pos-
teriorly, obscuring the glottis and making it difﬁcult
to visualise the airway. CT-scan showed a bilateral




▸ Lingual tonsillar hypertrophy
▸ Minor salivary gland tumour.
TREATMENT
The patient was electively taken to surgery for exci-
sional biopsy of the lesion, with a working
diagnosis of hypertrophic lingual tonsils.
Endotracheal intubation was attempted, however, it
was unsuccessful, and tracheostomy was performed
to secure the airway. The lesion (ﬁgure 1) was soft
and friable, pushing the epiglottis posteriorly and
obscuring the glottis. Excision was attempted on
the mass, but it was very friable, raising a clinical
suspicion of malignancy. A frozen section was sent,
which was inconclusive. Histopathology revealed
extranodal marginal zone lymphoma of
mucosa-associated lymphoid tissue (MALT lymph-
oma). Immunohistochemical stains showed diffuse
positivity for Pan B (CD20), Pan T (CD3) and
CD5, immunohistochemical stains highlighting
admixed mature T lymphocytes and Cyclin-D1,
CD10 and CD23 immunohistochemical stains were
negative (ﬁgures 2 and 3).
OUTCOME AND FOLLOW-UP
The patient underwent eight cycles of CHOP
therapy over 9 months and was then followed in
ENT clinic for the next 10 months on a monthly
bases in the outpatient clinic, with no evidence of
recurrence in this follow-up period.
DISCUSSION
Lymphomas of the head and neck account for about
3% of all lymphomas.3 MALT lymphoma of the
head and neck region is the second most common
after gastrointestinal tract (GIT),1 however, MALT
lymphoma of the tongue is a rare entity and has
only been reported in a few cases.1 MALT lymph-
omas arise on a background of chronic pre-existing
Figure 1 Intraoperative view of the lesion on both
sides of the base of the tongue, as seen orally.
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inﬂammatory disorders such as Helicobacter pylori infection of
the stomach or an autoimmune disorder.3
MALT tissue specialises in protection of mucosa that is in
direct contact with the external environment, unlike peripheral
lymph nodes, which deal with antigens presented by afferent
lymphatics.4 Peyer’s patches in the terminal ileum are a good
example of the true architecture of MALT tissue, which consists
of a centre follicle surrounded by a marginal zone and clusters
of marginal cell epithelium covering the epithelium.5 In the
head and neck region, they are commonly seen in the
Waldeyer’s ring and mostly involving the Palatine tonsils.6 In
the salivary glands, it is most commonly found in the parotid
gland and is associated with Sjögren’s syndrome.3
Two-thirds of cases are found in the GIT whereas the rest
have been reported in various sites such as the lungs, pharynx,
larynx, trachea, thyroid and salivary glands.6 MALT lymphomas
have certain hallmark features such as (1) centrocyte-like
tumour cells, (2) follicular colonisation, (3) lymph epithelial
lesions and (4) plasma cells.7 8 No speciﬁc marker is linked with
MALT lymphomas, however, they are known to express CD 20,
CD 21, CD 32, CD 35, CD43 and bcl-2, and they are deﬁned
by the absence of CD 5, CD 10 and CD 23.6
Malt lymphomas have an inert natural course of disease,3
they tend to remain in remission but at the time of relapse they
tend to occur in other extranodal sites.3 They have a better
prognosis even when high grade, as compared to their nodal
counterparts, since excision alone is suggested to be curative.9 10
Other authors have suggested radiotherapy to play the same
role.11 Deinbeck et al12 reported to have cured 30 patients with
marginal zone lymphoma with 40 Gy of radiation. Ueda et al13
reported extraintestinal MALT lymphoma to have a worse prog-
nosis with multiorgan involvement than gastric MALT lymph-
oma, even after chemotherapy.
There have been ﬁve previously reported cases of MALT
lymphoma of the tongue.1 3 14–16 One case was of a 62-year-old
woman who underwent conservative treatment and developed
systemic spread, and was then treated with chemotherapy 7 years
after diagnosis,14 another was of a patient with a 1.9×1.0 cm
tongue lymphoma who underwent surgical resection,16 two
other cases were of 61-year-old and 80-year-old women who
underwent only surgical resection,3 15 and the most recently
reported case was of a 29-year-old woman with a history of
T-cell lymphoma, developing MALT lymphoma at the base of
her tongue 3 years later, successfully treated with radiotherapy.1
There does not seem to be a consensus on the treatment of
MALT lymphoma, especially when found on the tongue.6 In
our case, the patient underwent surgical debulking followed by
chemotherapy, and remained disease-free 10 months after com-
pletion of treatment.
To the best of our knowledge, ours is the sixth reported case
of MALT lymphoma of the tongue.
Learning points
▸ Hypertrophic lingual tonsils may well be malignant, and one
should consider mucosa-associated lymphoid tissue
lymphoma in the differential diagnosis.
▸ Endotracheal intubation may be difﬁcult with a mass at the
base of the tongue, a retroﬂexed epiglottis, hence
tracheostomy should be considered.
▸ We suggest a biopsy for suspicious cases of tonsillar
hypertrophy.
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